Yamada Y - Search Results

1

Regression of optic disc neovascularization in patients with Behçet's uveoretinitis after infliximab therapy.

Kawaguchi T, Sugita S, Yamada Y, Miyanaga M, Mochizuki M. Kawaguchi T, et al. Among authors: yamada y. J Ocul Pharmacol Ther. 2010 Dec;26(6):627-30. doi: 10.1089/jop.2010.0031. Epub 2010 Nov 2. J Ocul Pharmacol Ther. 2010. PMID: 21043804

2

Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease.

Yamada Y, Sugita S, Tanaka H, Kamoi K, Kawaguchi T, Mochizuki M. Yamada Y, et al. Br J Ophthalmol. 2010 Mar;94(3):284-8. doi: 10.1136/bjo.2009.158840. Epub 2009 Aug 18. Br J Ophthalmol. 2010. PMID: 19692382

3

[Effects and safety of infliximab administration in refractory uveoretinitis with Behçet's disease].

Tanaka H, Sugita S, Yamada Y, Kawaguchi T, Iwanaga Y, Kamoi K, Yokota M, Takase H, Mochizuki M. Tanaka H, et al. Among authors: yamada y. Nippon Ganka Gakkai Zasshi. 2010 Feb;114(2):87-95. Nippon Ganka Gakkai Zasshi. 2010. PMID: 20187505 Japanese.

4

Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment.

Yamada Y, Sugita S, Tanaka H, Kamoi K, Takase H, Mochizuki M. Yamada Y, et al. Br J Ophthalmol. 2011 Feb;95(2):205-8. doi: 10.1136/bjo.2009.168856. Epub 2010 Jun 11. Br J Ophthalmol. 2011. PMID: 20542984

5

Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease.

Sugita S, Yamada Y, Mochizuki M. Sugita S, et al. Among authors: yamada y. Br J Ophthalmol. 2011 Apr;95(4):549-52. doi: 10.1136/bjo.2009.174888. Epub 2010 Jun 27. Br J Ophthalmol. 2011. PMID: 20584716

6

Induction of regulatory T cells by infliximab in Behcet's disease.

Sugita S, Yamada Y, Kaneko S, Horie S, Mochizuki M. Sugita S, et al. Among authors: yamada y. Invest Ophthalmol Vis Sci. 2011 Jan 21;52(1):476-84. doi: 10.1167/iovs.10-5916. Invest Ophthalmol Vis Sci. 2011. PMID: 20861484

7

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.

Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki M. Sugita S, et al. Among authors: yamada y. Arthritis Res Ther. 2012 May 1;14(3):R99. doi: 10.1186/ar3824. Arthritis Res Ther. 2012. PMID: 22546542 Free PMC article.

8

Psoriasis triggered by infliximab in a patient with Behçet's disease.

Kawazoe Y, Sugita S, Yamada Y, Akino A, Miura K, Mochizuki M. Kawazoe Y, et al. Among authors: yamada y. Jpn J Ophthalmol. 2013 Jan;57(1):95-7. doi: 10.1007/s10384-012-0198-4. Epub 2012 Oct 23. Jpn J Ophthalmol. 2013. PMID: 23090423

9

Mechanisms of immune suppression for CD8+ T cells by human corneal endothelial cells via membrane-bound TGFbeta.

Yamada Y, Sugita S, Horie S, Yamagami S, Mochizuki M. Yamada Y, et al. Invest Ophthalmol Vis Sci. 2010 May;51(5):2548-57. doi: 10.1167/iovs.09-4233. Epub 2009 Dec 10. Invest Ophthalmol Vis Sci. 2010. PMID: 20007827

10

Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells.

Horie S, Sugita S, Futagami Y, Yamada Y, Mochizuki M. Horie S, et al. Among authors: yamada y. Clin Immunol. 2010 Jul;136(1):83-95. doi: 10.1016/j.clim.2010.03.001. Epub 2010 Mar 29. Clin Immunol. 2010. PMID: 20350837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,929 results

Search Page

Filters